Fig. 6: Suggested model for a therapy approach based on expression and subtypes, to be used for testing ideas in future clinical trials.
From: Integrated molecular and clinical characterization of pulmonary large cell neuroendocrine carcinoma
The dashed line corresponds to a potential therapeutic target. NSCLC non-small cell lung cancer, SCLC small cell lung cancer.
